Innovative Advisory Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Innovative Advisory Group's XBI Position: Q3 2026 in Review
Innovative Advisory Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 134% in Q3 2026, buying an estimated $1.48M and bringing the position to 16,357 shares worth $2.58M. The position accounts for 1.88% of the portfolio, ranked #12.
Innovative Advisory Group first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.66M in Q4 2025. 964 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Innovative Advisory Group held 16,357 shares of State Street SPDR S&P Biotech ETF worth $2.58M as of Q3 2026.
- Innovative Advisory Group bought 9,359 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $1.48M.
- State Street SPDR S&P Biotech ETF made up 1.88% of Innovative Advisory Group's portfolio in Q3 2026, its #12 holding.
- Innovative Advisory Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
- Innovative Advisory Group's State Street SPDR S&P Biotech ETF position peaked at $2.66M in Q4 2025.
- 964 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Innovative Advisory Group's 13F filing for Q3 2026, filed 13 Oct 2026.